Abstract
Pompholyx, or dyshidrotic eczema, is a chronic dermatitis that mainly affects the hands and, less frequently, the feet. The condition causes highly pruritic vesicles to form on the palms and lateral aspects of the fingers, with some individuals experiencing a burning sensation. The etiology of pompholyx is thought to be multifactorial and is known to be exacerbated by a number of factors, including emotional stress, smoking, contact allergies, eczema, and compromised immune state. Treatment of pompholyx should aim to limit any known causal factors as well as address the inflammation seen in acute flares. Potent topical corticosteroids are first-line treatment. Individuals who do not respond to topical corticosteroids may be treated with a topical immunomodulators such as tacrolimus. The condition tends to be chronic and recurrent.
This is a preview of subscription content, log in via an institution to check access.
References
Wollina U. Pompholyx: a review of clinical features, differential diagnosis, and management. Am J Clin Dermatol. 2010;11(5):305–14.
Guillet MH, Wierzbicka E, Guillet S, Dagregorio G, Guillet G. A 3-year causative study of pompholyx in 120 patients. Arch Dermatol. 2007;143(12):1504–8.
Letić M. Use of sunglight to treat dyshidrotic eczema. JAMA Dermatol. 2013;149(5):634–5.
Lee KC, Ladizinski B. Dyshidrotic eczema following intravenous immunoglobullin treatment. CMAJ. 2013;185(11):E530.
Doshi DN, Cheng CE, Kimball AB. Chapter 16. Vesicular palmoplantar eczema. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012. Available from: http://accessmedicine.mhmedical.com.ezproxy.cul.columbia.edu/content.aspx?bookid=392&Sectionid=41138711. Accessed 18 Nov 2014.
Sehgal VN, Srivastava G, Aggarwal AK, Sharma AD. Hand dermatitis/eczema: current management strategy. J Dermatol. 2010;37(7):593–610.
Usatine RP, Riojas M. Diagnosis and management of contact dermatitis. Am Fam Physician. 2010;82(3):249–55. Review.
Kotan D, Erdem T, Acar BA, Boluk A. Dyshidrotic eczema associated with the use of IVIg. BMJ Case Rep. 2013. doi:10.1136/bcr-2012-008001.
Vecchietti G, Kerl K, Prins C, Kaya G, Saurat JH, French LE. Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion: report of 4 cases and review of the literature. Arch Dermatol. 2006;142(2):213–7.
Miyamoto J, Böckle BC, Zillikens D, Schmidt E, Schmuth M. Eczematous reaction to intravenous immunoglobulin: an alternative cause of eczema. JAMA Dermatol. 2014;150(10):1120–2.
Egan CA, Rallis TM, Meadows KP, Krueger GG. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol. 1999;40(4):612–4.
Wollina U, Karamfilov T. Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left-right comparison. J Eur Acad Dermatol Venereol. 2002;16(1):40–2.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Reich, D., Psomadakis, C.E., Buka, B. (2017). Pompholyx. In: Top 50 Dermatology Case Studies for Primary Care. Springer, Cham. https://doi.org/10.1007/978-3-319-18627-6_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-18627-6_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18626-9
Online ISBN: 978-3-319-18627-6
eBook Packages: MedicineMedicine (R0)